I den kliniske undersøgelse med GIST- patienter, oplevede 7 (5%) af patienterne CTC grad 3– 4: gastrointestinale blødninger (3 patienter), intra- tumorale blødninger (3 patienter) eller begge dele (1 patient).
In the GIST clinical trial, 7 (5%) patients experienced CTC grade 3/ 4 GI bleeds (3 patients), intra-tumoural bleeds (3 patients) or both (1 patient).